| Regulatory
Matters |
|
|
Becaplermin |
|
|
Clopidogrel |
|
|
Clopidogrel
and proton-pump inhibitors |
|
|
Deferasirox |
|
|
Dextropropoxyphene |
|
|
Didanosine |
|
|
Erythropoiesis-stimulating
agents |
|
|
Human
immune globulin |
|
|
Isotretinoin |
|
|
Long-acting
beta-agonists |
|
|
Natalizumab |
|
Safety of Medicines |
|
|
Cough
and cold medicines |
|
|
Fluoxetine |
|
|
H1N1
pandemic vaccines |
|
|
Saquinavir |
|
|
Seasonal
flu vaccine |
|
|
Serotonergic
agents |
|
|
Simvastatin |
|
|
Photosensitivity
reactions |
| Feature |
|
|
New
international collaboration for safer use of medicines and better
patient care |
|
|
WHO
Prequalification of Medicines Programme: Inspection of Finished Pharmaceutical
Product Manufacturers to increase quality of medicines |